PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MD Anderson research highlights for August 21, 2024

Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a new understanding of liver regeneration

2024-08-21
(Press-News.org) HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Targeting an enzyme as part of combination therapy disrupts gastric cancer progression
Many patients with gastric cancer have metastatic disease at the time of diagnosis, highlighting a need to identify pathways that control malignant progression. Researchers led by Pawel Mazur, Ph.D., identified a previously unrecognized lysine methyltransferase, SMYD5, that is highly expressed in patients with gastric cancer and is associated with poorer outcomes. The researchers found that SMYD5 specifically methylates the rpL40 protein, which remodels a particular region on ribosomes, resulting in increased new protein formation and cancer growth. Inhibiting SMYD5 in patient-derived and genetically engineered lab models blocked cancer cell growth and sensitized them to targeted therapy treatment. Further, SMYD5 inhibition combined with targeted therapy and chimeric antigen receptor (CAR) T cell therapy effectively eliminated aggressive gastric cancer in vivo, supporting the therapeutic potential of this combination. Learn more in Nature.

ADC shows promising results in treating HER2+ metastatic colorectal cancer
HER2 is overexpressed in some colorectal cancers, contributing to poor prognosis, brain metastases and resistance to anti-EGFR therapies. Findings from the DESTINY-CRC01 study suggested that the HER2-targeted antibody-drug conjugate (ADC), trastuzumab deruxtecan, might benefit patients with HER2 positive, RAS-wild-type metastatic colorectal cancer. In the Phase II DESTINY-CRC02 trial, led by Kanwal Raghav, M.D., M.B.B.S., researchers evaluated the safety and efficacy of two doses of trastuzumab deruxtecan in 122 patients from multiple countries, all of whom had undergone chemotherapy and targeted treatments. The results showed that the lower dose had a 37.8% objective response rate, compared to 27.5% with the higher dose. Both doses were generally well tolerated, but the lower dose had fewer severe side effects. This study led to Food and Drug Administration approval of trastuzumab deruxtecan for HER2+ metastatic colorectal cancer, underscoring the ADC as an effective treatment option for this challenging cancer type. Learn more in The Lancet Oncology.

LIFR regulates cholesterol-driven process for liver regeneration 
The liver is the only human organ that can fully regenerate, even after as much as 70% of it has been removed. New liver tissue can grow back to match the original organ’s size and functionality without turning into cancer, but how it does so remains unclear. White blood cells known as neutrophils recently have been implicated in this process, but the pathway involved in releasing neutrophils from the bone marrow after liver injury is poorly understood. Researchers led by Li Ma, Ph.D., uncovered new pathways orchestrated by leukemia inhibitory factor receptor (LIFR) to facilitate the regeneration process. When the liver is damaged, LIFR from hepatocytes – the most common liver cell type – promotes the production and secretion of cholesterol and the CXCL1 protein. While CXCL1 promotes the release of bone marrow neutrophils to the liver, cholesterol stimulates neutrophils to produce hepatocyte growth factor to induce hepatocyte proliferation. This novel role for cholesterol in the regenerative process of the liver could have potential clinical implications. Learn more in Nature Metabolism. 

Novel biomarker can stratify patients with large cell neuroendocrine carcinoma
Patients with large cell neuroendocrine carcinoma (LCNEC) have few treatment options and poor prognoses, highlighting the need to identify more effective therapeutic targets. By examining molecular data from preclinical models and patients, researchers led by Carl Gay, M.D., Ph.D., uncovered two distinct types of LCNEC based on the presence of the transcription factor YAP1. YAP1-high and YAP1-low LCNEC have different genetic and gene expression features, underscoring the need for individually tailored treatments. YAP1-low tumors resemble small cell lung cancers (SCLC), including several proteins targeted by emerging SCLC treatments. Conversely, YAP1-high tumors exhibit features suggesting they would benefit from immunotherapies and targeted therapies most associated with non-small cell lung cancers. These results suggest that YAP1 status could guide the application, or even development, of personalized treatments for patients with LCNEC. Learn more in Clinical Cancer Research.

Novel BCL2 inhibitor shows promise in relapsed CLL
Patients with newly diagnosed chronic lymphocytic leukemia (CLL) respond well to the B cell lymphoma 2 (BCL2) inhibitor, venetoclax, as their initial treatment, but an increasing number of patients will relapse. Many of these relapsed patients retain sensitivity to BCL2 inhibitors and also have elevated levels of other anti-apoptotic proteins, such as B-cell lymphoma extra-large (BCLXL). To improve patient outcomes, researchers led by Deepa Sampath, Ph.D., examined the mechanism of action and activity of LP-118, a highly potent inhibitor of BCL2 with moderate BCLXL inhibition, in preclinical studies.  Researchers observed reduction in tumor burden, survival advantages and low platelet toxicity. These results warrant further investigation and evaluation of the novel treatment in venetoclax-responsive and relapsed CLL. Learn more in Haematologica.

In case you missed it
Read below to catch up on recent MD Anderson press releases.

NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells Read this press release in the MD Anderson Newsroom.

END


ELSE PRESS RELEASES FROM THIS DATE:

Proatherogenic disorders of blood lipid and lipoprotein metabolism in patients with rheumatoid arthritis

Proatherogenic disorders of blood lipid and lipoprotein metabolism in patients with rheumatoid arthritis
2024-08-21
In the realm of chronic inflammation, lipid abnormalities are well-recognized as pivotal contributors to the progression and clinical manifestations of atherosclerosis. Particularly in rheumatoid arthritis (RA), a systemic autoimmune disorder, the immune response leads to the generation of inflammatory cytokines that profoundly alter lipid and lipoprotein metabolism. This review article delves into the latest research exploring the impact of inflammation on proatherogenic disorders of lipid and lipoprotein metabolism in RA patients, with a focus on proinflammatory cytokines. Role of Proinflammatory Cytokines in Lipid and Lipoprotein Dysregulation Inflammatory ...

Pioneering study shows effective regulation and monitoring is key to tackling emissions of a super-greenhouse gas

Pioneering study shows effective regulation and monitoring is key to tackling emissions of a super-greenhouse gas
2024-08-21
New research has revealed factories globally are not properly destroying one of the most potent greenhouse gases emitted from the production of fluoropolymers like Teflon, and refrigerants. The study investigated a known disparity between real and reported emissions of this gas, prompting calls for more countries to sign up to official agreements to limit emissions and for their Teflon factories to be independently audited to ensure compliance. The study, published today in the journal Nature, scrutinised emissions of one of the most potent hydrofluorocarbon (HFC) greenhouse gases called trifluoromethane, also ...

Inflammation during childhood linked to onset of mental health issues in early adulthood – study reveals

2024-08-21
Children who have persistently raised inflammation are at a higher risk of experiencing serious mental health disorders including psychosis and depression in early adulthood, according to a study published today in JAMA Psychiatry. The research lead by the University of Birmingham also found that those who had experienced inflammation at a young age were at a higher risk of developing cardiometabolic diseases such as insulin resistance - an early form of diabetes.  The study used data collected by the Avon Longitudinal Study of Parents and Children (ALSPAC) – also known as Children of the 90s – and included a total of 6,556 participants of whom 50.4% ...

Study finds sex-based disparities in outcomes after cardiac surgery

2024-08-21
Mass General Brigham researchers found that women had a lower risk of developing postoperative atrial fibrillation after surgery compared to men, but a higher risk of long-term mortality  New research suggests that women who develop postoperative atrial fibrillation (poAF) after cardiac surgery are at greater risk of death than men. A study led by Mass General Brigham researchers found that women may have protective factors against the development of poAF, but once it develops, they may be more vulnerable to its associated long-term morbidities. The researchers suggest that more vigilant monitoring and long-term ...

Study of 18 million people finds increased mental illnesses incidence following severe COVID-19, especially in unvaccinated people

2024-08-21
A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry today [21 August], investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status. COVID-19 is associated with mental illnesses in both hospital and population-based studies. However, until now, there was limited evidence about the association of COVID-19 with ...

Nearly 90 percent of NYC transit workers have been harassed or assaulted

2024-08-21
The COVID-19 pandemic brought an increase in crime to New York City’s subways and buses. The transit system’s employees—especially female workers—have frequently been on the receiving end of attacks, according to a new study published in the Journal of Urban Health. The study, led by researchers at the NYU School of Global Public Health, found that 89 percent of public-facing transit workers in New York City experienced harassment or violence on the job during the pandemic (2020-2023). “Transit workers are our city’s unsung heroes—they kept New York City functioning during the COVID-19 pandemic, ...

COVID-19 and mental illnesses in vaccinated and unvaccinated people

2024-08-21
About The Study: In this cohort study, depression, serious mental illness, general anxiety, posttraumatic stress disorder, eating disorders, addiction, self-harm, and suicide were elevated during weeks 1 through 4 after COVID-19 diagnosis compared with before or without COVID-19. Incidence was lower in people who were vaccinated when they had COVID-19 and incidence was higher, and persisted longer, after hospitalization for COVID-19. The findings support recommendation of COVID-19 vaccination in the general population and ...

New heaviest exotic antimatter nucleus

New heaviest exotic antimatter nucleus
2024-08-21
UPTON, N.Y. — Scientists studying the tracks of particles streaming from six billion collisions of atomic nuclei at the Relativistic Heavy Ion Collider (RHIC) — an “atom smasher” that recreates the conditions of the early universe — have discovered a new kind of antimatter nucleus, the heaviest ever detected. Composed of four antimatter particles — an antiproton, two antineutrons, and one antihyperon — these exotic antinuclei are known as antihyperhydrogen-4. Members of RHIC’s STAR Collaboration made the discovery by using their house-sized particle detector ...

Virtual learning in kindergarten through grade 12 during the COVID-19 pandemic and chronic absenteeism

2024-08-21
About The Study: Chronic absenteeism rates were substantially higher in school districts that used virtual learning during the COVID-19 pandemic compared with in person in this cross-sectional study. Understanding how to reduce chronic absenteeism and use virtual learning without potentially negative consequences are key policy questions moving forward.  Corresponding Author: To contact the corresponding author, William N. Evans, PhD, email wevans1@nd.edu. To access the embargoed study: ...

Self-repairing mitochondria use novel recycling system, study finds

Self-repairing mitochondria use novel recycling system, study finds
2024-08-21
Mitochondria, the so-called “powerhouse of the cell,” depend on a newly discovered recycling mechanism identified by scientists at The Hospital for Sick Children (SickKids).  Mitochondria are tiny structures inside of cells that carry out a wide range of critical functions, including generating energy to help keep cells healthy. Every mitochondrion has two layers of membranes: the outer membrane and the inner membrane. On the inner membrane, folds called cristae contain proteins and molecules needed for energy production. ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] MD Anderson research highlights for August 21, 2024
Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a new understanding of liver regeneration